RSS-Logo-2

GuerillaStockTrading Market Intelligence

Peleton $PTON Second Actor Has Heart Attack

PTON stock has recovered from an initial plunge on January 24, 2022, after it was reported that a second TV actor has had a heart attack after riding a Peleton bike. Second TV character has heart attack after riding Peloton Bike, CNBC reports A second television character appeared in a popular TV show having a heart attack after riding a …

Read more.
Peleton $PTON Second Actor Has Heart Attack

Exterran $EXTN Stock Surges 37% On Merger With Enerflex

Exterran $EXTN Stock Surges 37% On Merger With Enerflex
EXTN stock rose more than 37% in early trading on January 24, 2022, after the company announced a merger with Enerflex to form a global energy company. Enerflex Ltd. and Exterran Corporation to Combine, Creating a Premier Integrated Global Provider of Energy Infrastructure On January 24, 2022, Enerflex Ltd. (TSX: EFX) and Exterran Corporation (NYSE:EXTN) announced a business combination (the …

Read more.

KOHLs $KSS Up 30% On Buyout Rumors

KSS stock rose 30% in pre-market trading on January 24, 2022, as rumors circulated about a possible buyout. Kohl’s Confirms Receipt of Expressions of Interest Kohl’s Corporation (NYSE:KSS) confirmed that it has received letters expressing interest in acquiring the Company. The Kohl’s Board of Directors will determine the course of action that it believes is in the best interests of …

Read more.
KOHLs $KSS Up 30% On Buyout Rumors

Nationwide Risk-Managed Income ETF $NUSI Testing Major Support

NUSI stock chart
NUSI stock is testing a major two-year support level on the chart. Buzz is heating up about this major support level as analysts across the country focus in on this ETF. When income ETFs get hit like this, that's an immediate contraction in spending from retirees and anyone who relies on a steady stream of income from income-oriented investments. Achieving …

Read more.

Amazon $AMZN Australia Demand For Cloud AWS Surges

AMZN stock may see an upward move when markets open on January 24, 2022, after a press release by ISG Group stated that demand for Amazon AWS services is exploding from Australia due to COVID-19. Pandemic Accelerates Australian Digital Transformations, Leading More Firms to Seek Out AWS Provider Partners The effects of the COVID-19 pandemic have led more Australian enterprises …

Read more.
Amazon $AMZN Australia Demand For Cloud AWS Surges

Las Vegas Sands $LVS Stock Defies Gravity With Price Target Hike

Las Vegas Sands $LVS Stock Defies Gravity With Price Target Hike
LVS stock is defying the broad market sell-off as of January 23, 2022, showing excellent relative strength and bullish option flow. Bullish Option Flow Detected On January 21, 2022 Las Vegas Sands price target raised to $45 from $39 at Jefferies Jefferies analyst David Katz raised the firm's price target on Las Vegas Sands to $45 from $39 and keeps …

Read more.

Apple $AAPL Supplier Expects Incredible Q1 2022 Sales

What might be a bullish signal for $AAPL stock, an Apple iPhone parts supplier expects a huge Q1 2022 sales surge. iPhone assembler Hon Hai expects 'unprecedented' Q1, Bloomberg reports Key Apple (AAPL) iPhone assembler Hon Hai Precision (HNHPF) may achieve an "unprecedented" performance in the first quarter, Bloomberg's Debby Wu reports, citing Chairman Young Liu. "Our performance in the …

Read more.
Apple $AAPL Supplier Expects Incredible Q1 2022 Sales

ProKidney $DNAC to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III

ProKidney $DNAC to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III
DNAC stock is set to uptrend as the ProKidney SPAC and new ticker will go live sometime by Q3 2022. Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III On January 18, 2022, ProKidney LP (“ProKidney”), a leading clinical-stage cellular therapeutics company focused on chronic kidney disease (“CKD”), …

Read more.

Moderna $MRNA Stock Collapses As Boosters Don't Work Shocker?!

MRNA stock has crashed -67% from its 52-week high as news hits that its latest booster shot is not as effective against omicron as originally thought. Losses Top $130 Billion, Stock Down 67% from Highs Last Year Following Lackluster COVID Vaccine Results Battered by a steep broad-market selloff this week, Moderna shares fell for a sixth straight day Friday as …

Read more.
Moderna $MRNA Stock Collapses As Boosters Don't Work Shocker?!

Unsubscribe | Manage your subscription